The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Innovative Small Molecule Targeted Drugs Market Research Report 2024

Global Innovative Small Molecule Targeted Drugs Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1745217

No of Pages : 100

Ask Your Query

Synopsis
Global Innovative Small Molecule Targeted Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Innovative Small Molecule Targeted Drugs market research.

Key manufacturers engaged in the Innovative Small Molecule Targeted Drugs industry include Roche, Pfizer, Genetech, Novartis, Bayer, Abbive, Jiangsu Hengrui Pharmaceuticals, Jiangsu Chia Tai-Tianqing Pharmaceutical and QILU Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Innovative Small Molecule Targeted Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Innovative Small Molecule Targeted Drugs market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Innovative Small Molecule Targeted Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Roche
  • Pfizer
  • Genetech
  • Novartis
  • Bayer
  • Abbive
  • Jiangsu Hengrui Pharmaceuticals
  • Jiangsu Chia Tai-Tianqing Pharmaceutical
  • QILU Pharmaceutical
  • Betta Pharmaceuticals
  • Shanghai Junshi Biosciences
  • Shanghai Allist Pharmaceuticals
  • Shenzhen Chipscreen Biosciences
  • Innovent Biologics, Inc.
  • Hinova Pharmaceuticals

Segment by Type

  • Kinase Inhibitors
  • Epigenetic Inhibitors
  • Proteasome Inhibitor

Segment by Application

  • Hospital
  • Pharmacy

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Innovative Small Molecule Targeted Drugs report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Innovative Small Molecule Targeted Drugs Market Overview
1.1 Product Overview and Scope of Innovative Small Molecule Targeted Drugs
1.2 Innovative Small Molecule Targeted Drugs Segment by Type
1.2.1 Global Innovative Small Molecule Targeted Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Kinase Inhibitors
1.2.3 Epigenetic Inhibitors
1.2.4 Proteasome Inhibitor
1.3 Innovative Small Molecule Targeted Drugs Segment by Application
1.3.1 Global Innovative Small Molecule Targeted Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Innovative Small Molecule Targeted Drugs Market Size Estimates and Forecasts
1.4.1 Global Innovative Small Molecule Targeted Drugs Revenue 2018-2029
1.4.2 Global Innovative Small Molecule Targeted Drugs Sales 2018-2029
1.4.3 Global Innovative Small Molecule Targeted Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Innovative Small Molecule Targeted Drugs Market Competition by Manufacturers
2.1 Global Innovative Small Molecule Targeted Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Innovative Small Molecule Targeted Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Innovative Small Molecule Targeted Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Innovative Small Molecule Targeted Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Innovative Small Molecule Targeted Drugs, Product Type & Application
2.7 Innovative Small Molecule Targeted Drugs Market Competitive Situation and Trends
2.7.1 Innovative Small Molecule Targeted Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Innovative Small Molecule Targeted Drugs Players Market Share by Revenue
2.7.3 Global Innovative Small Molecule Targeted Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Innovative Small Molecule Targeted Drugs Retrospective Market Scenario by Region
3.1 Global Innovative Small Molecule Targeted Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Innovative Small Molecule Targeted Drugs Global Innovative Small Molecule Targeted Drugs Sales by Region: 2018-2029
3.2.1 Global Innovative Small Molecule Targeted Drugs Sales by Region: 2018-2023
3.2.2 Global Innovative Small Molecule Targeted Drugs Sales by Region: 2024-2029
3.3 Global Innovative Small Molecule Targeted Drugs Global Innovative Small Molecule Targeted Drugs Revenue by Region: 2018-2029
3.3.1 Global Innovative Small Molecule Targeted Drugs Revenue by Region: 2018-2023
3.3.2 Global Innovative Small Molecule Targeted Drugs Revenue by Region: 2024-2029
3.4 North America Innovative Small Molecule Targeted Drugs Market Facts & Figures by Country
3.4.1 North America Innovative Small Molecule Targeted Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Innovative Small Molecule Targeted Drugs Sales by Country (2018-2029)
3.4.3 North America Innovative Small Molecule Targeted Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Innovative Small Molecule Targeted Drugs Market Facts & Figures by Country
3.5.1 Europe Innovative Small Molecule Targeted Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Innovative Small Molecule Targeted Drugs Sales by Country (2018-2029)
3.5.3 Europe Innovative Small Molecule Targeted Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Innovative Small Molecule Targeted Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Innovative Small Molecule Targeted Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Innovative Small Molecule Targeted Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Innovative Small Molecule Targeted Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Innovative Small Molecule Targeted Drugs Market Facts & Figures by Country
3.7.1 Latin America Innovative Small Molecule Targeted Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Innovative Small Molecule Targeted Drugs Sales by Country (2018-2029)
3.7.3 Latin America Innovative Small Molecule Targeted Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Innovative Small Molecule Targeted Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Innovative Small Molecule Targeted Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Innovative Small Molecule Targeted Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Innovative Small Molecule Targeted Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Innovative Small Molecule Targeted Drugs Sales by Type (2018-2029)
4.1.1 Global Innovative Small Molecule Targeted Drugs Sales by Type (2018-2023)
4.1.2 Global Innovative Small Molecule Targeted Drugs Sales by Type (2024-2029)
4.1.3 Global Innovative Small Molecule Targeted Drugs Sales Market Share by Type (2018-2029)
4.2 Global Innovative Small Molecule Targeted Drugs Revenue by Type (2018-2029)
4.2.1 Global Innovative Small Molecule Targeted Drugs Revenue by Type (2018-2023)
4.2.2 Global Innovative Small Molecule Targeted Drugs Revenue by Type (2024-2029)
4.2.3 Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Innovative Small Molecule Targeted Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Innovative Small Molecule Targeted Drugs Sales by Application (2018-2029)
5.1.1 Global Innovative Small Molecule Targeted Drugs Sales by Application (2018-2023)
5.1.2 Global Innovative Small Molecule Targeted Drugs Sales by Application (2024-2029)
5.1.3 Global Innovative Small Molecule Targeted Drugs Sales Market Share by Application (2018-2029)
5.2 Global Innovative Small Molecule Targeted Drugs Revenue by Application (2018-2029)
5.2.1 Global Innovative Small Molecule Targeted Drugs Revenue by Application (2018-2023)
5.2.2 Global Innovative Small Molecule Targeted Drugs Revenue by Application (2024-2029)
5.2.3 Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Innovative Small Molecule Targeted Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Innovative Small Molecule Targeted Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Innovative Small Molecule Targeted Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Genetech
6.3.1 Genetech Corporation Information
6.3.2 Genetech Description and Business Overview
6.3.3 Genetech Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Genetech Innovative Small Molecule Targeted Drugs Product Portfolio
6.3.5 Genetech Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis Innovative Small Molecule Targeted Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bayer Innovative Small Molecule Targeted Drugs Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Abbive
6.6.1 Abbive Corporation Information
6.6.2 Abbive Description and Business Overview
6.6.3 Abbive Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Abbive Innovative Small Molecule Targeted Drugs Product Portfolio
6.6.5 Abbive Recent Developments/Updates
6.7 Jiangsu Hengrui Pharmaceuticals
6.6.1 Jiangsu Hengrui Pharmaceuticals Corporation Information
6.6.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.6.3 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolio
6.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.8 Jiangsu Chia Tai-Tianqing Pharmaceutical
6.8.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Corporation Information
6.8.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Description and Business Overview
6.8.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product Portfolio
6.8.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
6.9 QILU Pharmaceutical
6.9.1 QILU Pharmaceutical Corporation Information
6.9.2 QILU Pharmaceutical Description and Business Overview
6.9.3 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product Portfolio
6.9.5 QILU Pharmaceutical Recent Developments/Updates
6.10 Betta Pharmaceuticals
6.10.1 Betta Pharmaceuticals Corporation Information
6.10.2 Betta Pharmaceuticals Description and Business Overview
6.10.3 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolio
6.10.5 Betta Pharmaceuticals Recent Developments/Updates
6.11 Shanghai Junshi Biosciences
6.11.1 Shanghai Junshi Biosciences Corporation Information
6.11.2 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Description and Business Overview
6.11.3 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product Portfolio
6.11.5 Shanghai Junshi Biosciences Recent Developments/Updates
6.12 Shanghai Allist Pharmaceuticals
6.12.1 Shanghai Allist Pharmaceuticals Corporation Information
6.12.2 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Description and Business Overview
6.12.3 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolio
6.12.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
6.13 Shenzhen Chipscreen Biosciences
6.13.1 Shenzhen Chipscreen Biosciences Corporation Information
6.13.2 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Description and Business Overview
6.13.3 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product Portfolio
6.13.5 Shenzhen Chipscreen Biosciences Recent Developments/Updates
6.14 Innovent Biologics, Inc.
6.14.1 Innovent Biologics, Inc. Corporation Information
6.14.2 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Description and Business Overview
6.14.3 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product Portfolio
6.14.5 Innovent Biologics, Inc. Recent Developments/Updates
6.15 Hinova Pharmaceuticals
6.15.1 Hinova Pharmaceuticals Corporation Information
6.15.2 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Description and Business Overview
6.15.3 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolio
6.15.5 Hinova Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Innovative Small Molecule Targeted Drugs Industry Chain Analysis
7.2 Innovative Small Molecule Targeted Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Innovative Small Molecule Targeted Drugs Production Mode & Process
7.4 Innovative Small Molecule Targeted Drugs Sales and Marketing
7.4.1 Innovative Small Molecule Targeted Drugs Sales Channels
7.4.2 Innovative Small Molecule Targeted Drugs Distributors
7.5 Innovative Small Molecule Targeted Drugs Customers
8 Innovative Small Molecule Targeted Drugs Market Dynamics
8.1 Innovative Small Molecule Targeted Drugs Industry Trends
8.2 Innovative Small Molecule Targeted Drugs Market Drivers
8.3 Innovative Small Molecule Targeted Drugs Market Challenges
8.4 Innovative Small Molecule Targeted Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock